PCV22 CASE-BASED-COSTING VS. MARKOV-MODELLING—A COMPARISON OF COST-EFFECTIVENESS-ANALYSES FOR CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE
Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67434-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)67434-7/fulltext
Section Title :
Section Order :
679
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67434-7&doi=10.1016/S1098-3015(10)67434-7